Minimal clinically important difference on the Beck Depression Inventory - II according to the patient's perspective

Button, Katherine S; Kounali, Daphne‐Zacharenia; Thomas, Leonie B; Wiles, Nicola; Peters, Tim J.; Welton, Nicky J; Ades, A E; Lewis, Glyn

doi:10.1017/s0033291715001270

Cited by 240 publications

(233 citation statements)

References 24 publications

Supporting

Mentioning

210

Contrasting

Unclassified

Order By: Relevance

“…Our preliminary data suggest that marijuana users experiencing subsyndromal depression symptoms at the start of a monitored abstinence period may experience a reduction in those symptoms. The average percent reduction in BDI-II scores (~37%) relative to baseline for the MJ group was above the minimal clinically significant difference cutoff (>17%) (Button et al 2015), which suggests clinically important improvements were observed in some individuals.…”

Section: Discussionmentioning

confidence: 92%

See 1 more Smart Citation

Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users

et al. 2017

View full text Add to dashboard Cite

Rationale Advancing marijuana prevention and intervention efforts is important given decreasing perception of harm among adolescents and increasing marijuana legalization. Objectives This study evaluates how a monitored abstinence protocol may contribute to emotional functioning and changes in marijuana problems that can enhance successful outcomes for non-treatment seeking adolescent marijuana users. Methods Adolescent marijuana users (n=26) and demographically matched controls (n=30) completed 28-days of monitored abstinence confirmed by bi-weekly urine toxicology. Participants were given measures of emotional functioning, marijuana use symptoms, and reward sensitivity during monitored abstinence. Results All participants (N=56) completed the protocol, and 69% of marijuana users (n=18 of 26) were confirmed abstinent for 28-days, with all users showing decreasing marijuana use. Reductions in subsyndromal depression, positive marijuana use expectancies, and poor sleep quality were observed by the end of the monitored abstinence period (n=26, ps<.05). Marijuana users also reported more attentional impulsivity and less responsiveness to reward stimuli during the second week of abstinence compared to controls. Later age of onset of regular marijuana use and more cumulative lifetime use was associated with a greater degree of emotional change and increased recognition of the negative effects of marijuana use. Conclusions Monitored abstinence programs may be beneficial in reducing marijuana use, subsyndromal emotional distress symptoms, and changing beliefs about marijuana use. Future prevention and intervention efforts may consider targeting reward sensitivity and impulsivity, in addition to marijuana use, expectancies, and emotional functioning.

show abstract

Section: Discussionmentioning

confidence: 92%

“…The average percent reduction in scores relative to baseline for MJ was 36.6% compared to 9.5% for controls. The suggested minimal clinically significant difference cutoff is 17% (Button et al 2015). No significant differences (between-group, within-subject, or Group by Time interactions) were identified for self-reported anxiety ( p s>.05)…”

Section: Resultsmentioning

confidence: 99%

Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users

et al. 2017

View full text Add to dashboard Cite

show abstract

“…On the BDI, clinically significant change was defined as an 18% reduction in total score (Button et al, 2015). On the CAPS, a 15-point change indicates clinically significant change (Weathers et al, 2001).…”

Section: Resultsmentioning

confidence: 99%

Developing an Emotion- and Memory-Processing Group Intervention for PTSD with complex features: a group case series with survivors of repeated interpersonal trauma

Clifford

Meiser‐Stedman

Johnson

et al. 2018

European Journal of Psychotraumatology

View full text Add to dashboard Cite

Individuals who experience repeated interpersonal trauma exposure often present with posttraumatic stress disorder (PTSD) with more complex features. There is currently no consensus regarding whether current evidence-based interventions for PTSD need to be tailored to better account for these complex features. However, one recommended adaptation is to adopt a phase-based or sequenced approach involving three phases, each with a distinct function. This paper describes the development of a 12-session Emotion- and Memory-Processing Group Programme, adapted from Cloitre’s Skills Training in Affective and Interpersonal Regulation (STAIR) phase-based treatment protocol. A single case series provided a preliminary examination of the group-based intervention’s efficacy for three groups of women with a history of repeated interpersonal trauma and PTSD with complex features (N = 15; age 19–46 years) at The Haven Sexual Assault Referral Centre in London. Results revealed significant reductions in: PTSD, complex features of PTSD, and depression, along with improvements in process measures of maladaptive cognitions and emotion processing. Results from this case series demonstrate that an Emotion- and Memory-Processing Group Programme holds promise for treating individuals with a history of interpersonal trauma in outpatient settings, and provides evidence to warrant the completion of a feasibility trial.

show abstract

“…Therefore we reanalyzed the number of patients who displayed deterioration until the end of treatment. As criterion for deterioration, we used the recommended threshold of a 17.5% increase in BDI scores which has been evaluated as minimal clinically important difference of the BDI [47]. For the intention-to-treat analysis, deterioration rates of patients were not significantly different between treatment groups, with 9.8% ( n = 4) in the CBASP group, 8.9% ( n = 4) in the CBT-E and 5.7% ( n = 3) in the CBT-M group.…”

Section: Resultsmentioning

confidence: 99%

Comparing the Efficacy of CBASP with Two Versions of CBT for Depression in a Routine Care Center: A Randomized Clinical Trial

Rief¹,

Bleichhardt²,

Dannehl³

et al. 2018

Psychother Psychosom

View full text Add to dashboard Cite

Background: The cognitive-behavioral analysis system of psychotherapy (CBASP) was developed for the treatment of chronic, early-onset depression. However, it is unclear whether this approach can be recommended for depression in general (episodic and chronic), and no direct comparisons between CBASP with different versions of cognitive-behavioral therapy (CBT) exist. Methods: A randomized controlled trial compared 3 treatment conditions (all lasting 16 sessions) with a waiting list group (WL): CBASP, CBT with a focus on physical exercise (CBT-E), and CBT with a focus on pleasurable, low-energy and mindful activities (CBT-M). We included 173 patients and involved 41 therapists. Assessments were at baseline, after session 8, and at the end of treatment. Results: Our primary outcome Beck Depression Inventory-II indicated a general advantage of the CBT arms compared to CBASP [F(6, 154.5) = 4.2, p = 0.001], with significant contrasts in particular in favor of CBT-E. Effect sizes against WL were d = 0.91 (CBT-E), 0.87 (CBT-M), and 0.47 (CBASP). A triple interaction with an additional factor “chronic versus episodic depression” [F(6, 142.7) = 2.2, p = 0.048] indicated that the treatments resulted in different outcomes, with best results again for CBT-E in particular in episodic depression. Responder rates indicated significant improvements (56% in both CBT arms, 34% in the CBASP arm, 3.4% in WL; intention-to-treat samples). As compared to CBASP, response rates were significantly higher for CBT-E (OR = 2.48; 95% CI = 1.02–6.00) and CBT-M (OR = 2.46; 95% CI = 1.01–6.01). Conclusions: CBASP was more effective than WL, but less effective than the 2 CBT arms. This was mainly caused by an advantage of CBT interventions in episodic depression.

show abstract

Minimal clinically important difference on the Beck Depression Inventory - II according to the patient's perspective

Cited by 240 publications

References 24 publications

Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users

Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users

Developing an Emotion- and Memory-Processing Group Intervention for PTSD with complex features: a group case series with survivors of repeated interpersonal trauma

Comparing the Efficacy of CBASP with Two Versions of CBT for Depression in a Routine Care Center: A Randomized Clinical Trial

Contact Info

Product

Resources

About